- Andre Choulika, CEO Cellectis
- Guna Rajagopal, VP – Global Head, Computational Sciences, Discovery Sciences Janssen
- Lorenz Mayr, VP & Global Head, Reagents & Assay Development Astrazeneca
- Zheng-Yi Chen, Associate Professor Harvard Medical School
- Daniel Anderson, Associate Professor MIT
- Marcello Maresca, Associate Principal Scientist Astrazeneca
- John Doench, Director; Associate Director, Genetic Perturbation Platform Broad Institute
- Chad Cowan, Associate Professor Harvard
- Pablo Perez Pinera, Associate Professor University of Illinois
- Jim Collins, Professor MIT
- Channabasavaiah Gurumurthy, Director, Transgenic Core Facility University of Nebraska Medical School
- Danilo Maddalo, Senior Scientist and Lab Head Novartis Institutes for BioMedical Research
- Rodolphe Barrangou, Associate Professor North Carolina State University
- Stephanie Mohr, DRSC Director Harvard Medical School
- Robert Howes, Associate Director MedImmune
- Channabasavaiah Gurumurthy, Director, Transgenic Core Facility University of Nebraska Medical Center
- James Carothers, Assistant Professor University of Washington
- William Theodorus Hendriks, Instructor in Neurology Harvard Medical School
- Mark Osborn, Assistant Professor University of Minnesota
- Jeff Chamberlain, Professor University of Washington
1 and 19 were counted at Genome Editing USA Congress #OxfordGlobal. Learn more at GenderAvenger Tally
Sadly this is a consistent pattern for Oxford Global. See for example Oxford Global Sequencing Meetings: Where MEN Tell You About Sequencing #YAMMM and also Time to boycott Oxford Global meetings due to blatant sexism
Really - we need as a community to stand up to these types of meetings. Oxford Global meetings should be boycotted. And the companies that sponsor their meetings are complicit in their gender bias.
---------------------------------------------
UPDATE 10/2 12:56 PM - decided to look at another one of their meetings that is linked from this one
2nd Annual Next Generation Sequencing USA Congress
3-4 October 2016, Boston, USA
83 % male speakers. Grand.
- James Knight, Director of Bioinformatics Yale University
- John Quackenbush, Professor Dana-Farber Cancer Institute
- Shanrong Zhao, Director Pfizer Inc.
- Nazneen Aziz, Research Professor Arizona State University
- George Weinstock, Director and Professor Jackson Laboratory for Genomic Medicine
- Alexander Wait Zaranek, Director Informatics Harvard Medical School
- Rong Mao, Medical Director, Molecular Genetics and Genomics, ARUP Laboratories; Associate Professor, Pathology University of Utah School of Medicine
- Mark Gerstein, Albert L Williams Professor of Biomedical Informatics, Molecular Biophysics & Biochemistry, and Computer Science Co-Director of the Yale Program in Computational Biology & Bioinformatics
- James Willey, Professor of Medicine and Pathology University of Toledo
- Neil R. Smalheiser, Associate Professor in Psychiatry University of Illinois College of Medicine
- Mark Borodovsky, Regents’ Professor Georgia Tech
- Scott J. Tebbutt, Associate Professor & Chief Scientific Officer University of British Columbia & PROOF Centre of Excellence
- Michael Fraser, Program Director, Cancer Genomics, Radiation Medicine Program Princess Margaret Cancer Centre
- Justin Johnson, Associate Director and Principal Scientist AstraZeneca
- Leonora Balaj, Instructor in Neurology Massachusetts General Hospital Harvard Medical School
- Aleksandra Markovets, Senior Scientist AstraZeneca
- Baohong Zhang, Director of Clinical Bioinformatics Pfizer, Inc.
- Steven Hart, Assistant Professor of Biomedical Informatics Mayo Clinic
- Manolis Kellis, Professor and Head, MIT Computational Biology Group MIT
- John Methot, Head of Scientific Computing Biogen
- Andrew Hollinger, Associate Director: Scientific Communications Broad Institute
- Yingtao Bi, Senior Manager in Statistics Abbvie Bioresearch Center
- Paul Blainey, Assistant Professor of Biological Engineering, MIT and Core Faculty Member Broad Institute of MIT & Harvard
For other posts on STEM Diversity see here.
That's why some courses in liberal arts like gender have to be required to science students and we should not encourage our children to focus on STEM courses only in K-12.
ReplyDelete